A vaccine being tested by University of Pittsburgh researchers could one day prevent some breast cancers before they become invasive — potentially stopping the disease before it truly starts. The experimental vaccine builds on decades of research by Pitt cancer researcher Dr. Olivera Finn, whose work identifying a molecule associated

Bruno and colleagues provide an overview of tertiary lymphoid structures as biomarkers and potential therapeutic targets in the cancer immunotherapy era.

This work reports the clinical outcomes of bacteriophage therapy for a recalcitrant Pseudomonas aeruginosa periprosthetic joint infection, demonstrating infection control through biofilm disruption an...

Abstract. Purpose: This treat-and-resect clinical study evaluated a specialized form of pulsed electric field (PEF) ablation’s potential to modulate antitumor immunity in early-stage non-small cell lu...

For more than a century, antibiotics have been medicine's go-to weapon against bacterial infections. But as drug-resistant bacteria become increasingly...

April 27, 2026University of Pittsburgh Department of Immunology faculty and students are advancing understanding of fundamental immune mechanisms and developing new approaches for diagnosing and treat...

Nature Microbiology, Published online: 22 April 2026; doi:10.1038/s41564-026-02294-7Single-cell RNA sequencing is used to study the sexual development of Toxoplasma gondii in cats, generating a transcriptional atlas and showing that the female-specific gene AP2X6 functions as a regulator of oocyst formation.